The section describes the author's early efforts to advocate for the use of [restricted term] as an all-encompassing treatment for COVID-19. During a global health emergency with few available treatments, Kory felt driven to explore a cost-effective, widely available drug known for its established safety profile and growing reputation for effectiveness against SARS-CoV-2. The book chronicles the collaboration between Dr. Paul Marik and the author, detailing the formation of the FLCCC Alliance and their unwavering dedication to disseminating vital treatment protocols to a worldwide audience seeking guidance.
Kory meticulously chronicled his experiences, culminating in a thorough understanding of [restricted term]'s potential to mitigate the severe effects of COVID-19. The book describes how the FLCCC, motivated by a significant lack of effective treatments and fully aware of the severe outcomes manifesting in healthcare facilities worldwide, identified [restricted term] as a possible treatment option.
Leveraging his extensive experience in treating respiratory conditions and providing intensive medical treatment, Kory took a proactive approach to COVID-19, distinguishing it from the cautious "wait-and-see" approach recommended by major health organizations and academic medical centers at the onset of the pandemic. Faced with the unique trajectory of illness that marked COVID respiratory failure, Kory worked tirelessly to identify and refine effective treatment options for his patients.
With more than ten years of experience in managing septic shock, Kory had a keen understanding of the potentially lethal outcomes of cytokine storms, characterized by an excessive immune reaction that causes the body to harm its own cells and tissues, potentially resulting in fatality. Pierre Kory was taken aback to find that a considerable number of doctors and medical facilities around the world often overlooked the importance of corticosteroids and intravenous vitamin C in controlling severe immune responses in critical care when he was addressing the treatment of COVID-19.
The writer diligently observed the unfolding events within the confines of the metropolis known as New York City. His alarm intensified as he continued to share insights with former colleagues from the critical care unit and became aware of the disturbingly elevated mortality rates. Dr. Mayo described the intensive care unit as a space crowded with numerous patients who were on ventilators. Since the first COVID-19 patients were received, not a single individual within the Mayo hospital network had been successfully weaned off mechanical breathing assistance. Even with the provision of the most comprehensive supportive care available, the outlook for the patients remained bleak. The potential of [restricted term] as a treatment for COVID-19 was still awaiting acknowledgment.
Pierre Kory's concerns arose from the observed lack of action. In a Senate hearing with Senator Ron Johnson, he would later claim that the healthcare providers were neglecting to deliver adequate treatment. In the United States, the initial strategy during the pandemic...
Unlock the full book summary of The War on Ivermectin by signing up for Shortform.
Shortform summaries help you learn 10x better by:
Here's a preview of the rest of Shortform's The War on Ivermectin summary:
The book thoroughly compiles substantial evidence that advocates for the utilization of [restricted term] as a means to treat and prevent COVID-19, and then methodically outlines how [restricted term] became a part of their treatment protocol for the illness. The book highlights the widespread use of [restricted term] in Peru, the reliability of simultaneous meta-analyses by respected scientists, and the author's own experiences with the successful employment of [restricted term] in combating the illness. They remain baffled by the stance of certain individuals who maintain that there is inadequate proof to support its use, even though they themselves hesitate to recommend it.
The author documents the astonishing amount of scientific evidence amassed from numerous sources, which consistently shows the ability of [restricted term] to significantly reduce mortality, hospitalization, and viral replication, not only in clinical trials but also in...
Kory was baffled by the unwavering opposition to the substantial body of research supporting the efficacy of [restricted term]. He details his exploration of the tactics that form the basis of a deliberate and misleading attack on his work and the endeavors of his peers in the medical and scholarly communities.
Kory meticulously examines the sometimes unethical and occasionally illegal activities of pharmaceutical companies, driven by their quest for higher profits. Kory frequently refers to the industries with the moniker "Big Harma."
The book highlights the pharmaceutical industry's accumulation of billions in fines for various infractions, including the concealment of crucial safety data, providing incentives to medical professionals and researchers, Medicare fraud,...
This is the best summary of How to Win Friends and Influence People I've ever read. The way you explained the ideas and connected them to other books was amazing.
The author delves into the broader and potentially disastrous repercussions of this conflict. The consequences go further than limiting a single drug, affecting not only the direction of future healthcare but also the credibility of our institutions and the overall well-being of society.
Pierre Kory believes that the concerted attempts to undermine the credibility of effective medications that are no longer under patent protection have caused potentially unparalleled damage to public health.
Kory argues that the intentional concealment of evidence favoring HCQ and [restricted term] by health organizations and scientific institutions constitutes a serious violation. Pierre Kory firmly believes that the actions taken have led to a mortality rate that, while challenging to measure, certainly reaches into the millions, if not tens of millions.